Disclosure Of Cash Flow Statement [Text Block]

Ascelia Pharma - Filing #701899

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Disclosure of cash flow statement [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
261 599 SEK
184 686 SEK
108 516 SEK
Income taxes paid (refund) [abstract]
Income taxes paid (refund), classified as operating activities
1 020 SEK
89,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.